MEDXF
Medexus Pharmaceuticals Inc
CEO
Kenneth D'Entremont
Industry
Medicinal and Botanical Manufacturing
Loading...
Open
1.75
Mkt cap
56M
Volume
300
High
1.76
P/E Ratio
11.60
52-wk high
3.88
Low
1.73
Div yield
N/A
52-wk low
1.08
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.